Market Cap ₹187 Cr.
Stock P/E -69.2
P/B 3.8
Current Price ₹174.8
Book Value ₹ 46.3
Face Value 10
52W High ₹349
Dividend Yield 0%
52W Low ₹ 160
HCP Plastene Bulkpack Ltd manufactures and sells technical textiles in India. It gives block bottom valve bags for cement packing; biaxially orientated polypropylene laminated baggage for packing chakki atta, rice, fertilizers and chemical substances, seeds, grains and pulses, tea and espresso, meals and spices, animal feeds, white cements and wall putties, outer packing, and product promotions; polypropylene woven sacks to be used in industries, along with cement, fertilizer, sugar, chemical substances, meals grains, and so on.; FIBC bags; and fabric/labels/laces for garment producers and exporters. It additionally exports its merchandise. The organization became formerly called Gopala Polyplast Ltd and modified its name to HCP Plastene Bulkpack Ltd in October 2021. The business enterprise was integrated in 1984 and is primarily based in Ahmedabad, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 11 | 11 | 79 | 111 | 94 | 69 | 77 | 59 | 79 | 80 |
| Other Income | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total Income | 11 | 11 | 79 | 113 | 94 | 69 | 77 | 60 | 80 | 80 |
| Total Expenditure | 11 | 9 | 75 | 106 | 90 | 66 | 74 | 58 | 74 | 75 |
| Operating Profit | -0 | 3 | 4 | 7 | 4 | 3 | 3 | 2 | 6 | 5 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 1 | 1 | 3 | 0 | -1 | -2 | -3 | 1 | 0 |
| Provision for Tax | -1 | -0 | 0 | 1 | 0 | -0 | -1 | -1 | 0 | 0 |
| Profit After Tax | -2 | 1 | 1 | 2 | 0 | -1 | -1 | -2 | 1 | 0 |
| Adjustments | 0 | 0 | -0 | -2 | -1 | 0 | 0 | 1 | -1 | -1 |
| Profit After Adjustments | -2 | 1 | 1 | 0 | -1 | -0 | -1 | -2 | 0 | -0 |
| Adjusted Earnings Per Share | -1.8 | 1.1 | 0.8 | 0.4 | -1 | -0.2 | -0.9 | -1.4 | 0.2 | -0.4 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|
| Net Sales | 16 | 112 | 352 | 295 |
| Other Income | 0 | 1 | 0 | 1 |
| Total Income | 16 | 113 | 352 | 297 |
| Total Expenditure | 20 | 107 | 334 | 281 |
| Operating Profit | -3 | 6 | 18 | 16 |
| Interest | 1 | 4 | 10 | 11 |
| Depreciation | 5 | 5 | 7 | 8 |
| Exceptional Income / Expenses | 53 | 0 | 0 | 0 |
| Profit Before Tax | 44 | -3 | 1 | -4 |
| Provision for Tax | -20 | -1 | 0 | -2 |
| Profit After Tax | 64 | -2 | 1 | -2 |
| Adjustments | 0 | 0 | -3 | -1 |
| Profit After Adjustments | 64 | -2 | -2 | -3 |
| Adjusted Earnings Per Share | 62.2 | -2.4 | -1.9 | -2.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 214% | 0% | 0% | 0% |
| Operating Profit CAGR | 200% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -37% | 97% | 40% | 27% |
| ROE Average | 2% | 78% | 78% | 78% |
| ROCE Average | 7% | 26% | 26% | 26% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Shareholder's Funds | 26 | 26 | 50 |
| Minority's Interest | 0 | 11 | 14 |
| Borrowings | 38 | 88 | 82 |
| Other Non-Current Liabilities | -24 | -20 | -22 |
| Total Current Liabilities | 8 | 46 | 51 |
| Total Liabilities | 49 | 150 | 175 |
| Fixed Assets | 27 | 79 | 83 |
| Other Non-Current Assets | 9 | 11 | 14 |
| Total Current Assets | 12 | 60 | 79 |
| Total Assets | 49 | 150 | 175 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 0 | 0 |
| Cash Flow from Operating Activities | -16 | -23 | -20 |
| Cash Flow from Investing Activities | -1 | -57 | -13 |
| Cash Flow from Financing Activities | 14 | 81 | 34 |
| Net Cash Inflow / Outflow | -3 | 0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 |
| # | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Earnings Per Share (Rs) | 62.17 | -2.39 | -1.9 |
| CEPS(Rs) | 67.18 | 2.73 | 7.63 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 25.71 | 25.08 | 46.93 |
| Core EBITDA Margin(%) | -23.54 | 5.02 | 5.04 |
| EBIT Margin(%) | 282.3 | 0.92 | 3.09 |
| Pre Tax Margin(%) | 274.26 | -2.82 | 0.34 |
| PAT Margin (%) | 400.86 | -2.18 | 0.22 |
| Cash Profit Margin (%) | 433.14 | 2.49 | 2.32 |
| ROA(%) | 130.65 | -2.46 | 0.47 |
| ROE(%) | 241.86 | -9.43 | 2.01 |
| ROCE(%) | 69.67 | 1.04 | 7.08 |
| Receivable days | 76.18 | 49.03 | 28.34 |
| Inventory Days | 151.98 | 51.64 | 27.23 |
| Payable days | 245.56 | 63.38 | 19.21 |
| PER(x) | 0.15 | 0 | 0 |
| Price/Book(x) | 0.35 | 23.13 | 4.05 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 2.97 | 6.26 | 0.92 |
| EV/Core EBITDA(x) | -13.48 | 111.82 | 17.94 |
| Net Sales Growth(%) | 0 | 606.91 | 213.3 |
| EBIT Growth(%) | 0 | -97.69 | 949.95 |
| PAT Growth(%) | 0 | -103.85 | 131.08 |
| EPS Growth(%) | 0 | -103.85 | 20.78 |
| Debt/Equity(x) | 1.44 | 4.24 | 2.44 |
| Current Ratio(x) | 1.5 | 1.3 | 1.56 |
| Quick Ratio(x) | 0.68 | 0.76 | 1.02 |
| Interest Cover(x) | 35.12 | 0.25 | 1.12 |
| Total Debt/Mcap(x) | 4.08 | 0.18 | 0.6 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 92.83 | 92.83 | 88.99 | 88.99 | 88.99 | 88.99 | 88.99 | 88.99 | 76.39 | 75 |
| FII | 0.18 | 0.18 | 0.17 | 0.17 | 0.17 | 0.18 | 0.18 | 0.18 | 0.18 | 0.17 |
| DII | 5 | 5 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
| Public | 1.99 | 1.99 | 6.04 | 6.04 | 6.04 | 6.03 | 6.03 | 6.03 | 18.64 | 20.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.82 | 0.8 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Public | 0.02 | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.2 | 0.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.02 | 1.02 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
